The REPROCELL Blog

The Benefits of Human Tissue to Drug Discovery and Development

[fa icon="calendar'] Mar 27, 2018 7:00:00 AM / by Karen Mcaulay posted in Drug Discovery, Human Tissues

[fa icon="comment"] 0 Comments

Progressive and innovative Pharmaceutical and Biotechnology companies ask themselves several key questions when it comes to Drug Discovery and Development:

• How and where can we be research smarter? 
• How can we reduce uncertainty? 
• How can we better predict efficacy and safety? 
• How can we reduce costs?

One route to making the drug discovery process smarter and more efficient is to use human tissue at one or more stages in the development process.

Continue reading [fa icon="long-arrow-right"]

Xeno-free culture of pluripotent stem cells in NutriStem® hPSC XF medium

[fa icon="calendar'] Feb 5, 2018 5:58:00 AM / by Robert Annand posted in Drug Discovery, Human Tissues, Stem Cells

[fa icon="comment"] 0 Comments

Pluripotent stem cells (PSCs), such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), are a key component of the growing field of regenerative medicine. Use of culture conditions free of animal products (xeno-free) is essential for PSC projects that are destined for the clinic. NutriStem hPSC XF medium (01-0005) and iMatrix-511 recombinant human laminin-511 E8 fragments (NP8920911) form an ideal system for xeno-free, feeder culture of human PSCs.

 

Check out our NutriStem Midwinter Sale

15% - 35% and more off 500 mL bottles.

Find out more →

Offer expires 15 March 2018. Offer not valid in Asia.

Continue reading [fa icon="long-arrow-right"]

Formation of human tissue to improve drug testing and reduce animal research

[fa icon="calendar'] Jan 19, 2018 9:30:56 AM / by Simon Padbury posted in Drug Discovery, Human Tissues, 3D Cell Culture, Bio-engineered Tissue Models

[fa icon="comment"] 0 Comments

REPROCELL’s Alvetex, a scaffold for 3D cell culture and bioengineered tissue models, is in the Durham University (UK) News yesterday, at https://www.dur.ac.uk/news/newsitem/?itemno=33385

Developed at the university by Professor Stefan Prsyborski, Alvetex was first commercialised by the spin-out company Reinnervate – based at NETPark in County Durham, UK. Reinnervate was acquired by REPROCELL Inc. (Japan) in 2014.

Stefan Przyborski is Professor of Cell Technology at Durham University’s Department of Biosciences and Chief Scientific Officer of REPROCELL Europe Ltd.

Continue reading [fa icon="long-arrow-right"]

Stay informed

Sign up to receive information from REPROCELL about our products, services, applications, promotions, and news (includes a weekly blog update email).

Recent Posts